Circulating Tumor DNA in KRAS positive colorectal cancer patients as a prognostic factor - a systematic review and meta-analysis

被引：11

作者：

Perdyan, Adrian ^{[1
]}

Spychalski, Piotr ^{[2
]}

Kacperczyk, Justyna ^{[3
]}

Rostkowska, Olga ^{[2
]}

Kobiela, Jarek ^{[2
]}

机构：

[1] Med Univ Gdansk, Dept Gen Endocrine & Transplant Surg, Student Sci Circle, Gdansk, Poland

[2] Med Univ Gdansk, Dept Gen Endocrine & Transplant Surg, Gdansk, Poland

[3] Univ Warmia & Mazury, Students Sci Soc Gen Minimally Invas & Elderly Su, Coll Medium, Olsztyn, Poland

来源：

CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY | 2020年 / 154卷

关键词：

colorectal cancer; circulating tumor DNA; KRAS; prognostic Factor; CELL-FREE DNA; ALLELE-SPECIFIC IMBALANCE; CODON; 12; GENE-MUTATIONS; BRAF MUTATIONS; LIQUID BIOPSY; CHEMOTHERAPY; ASSOCIATION; WORSE; CATEGORIZATION;

D O I：

10.1016/j.critrevonc.2020.103065

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Background: Liquid biopsy is a novel tool in oncology. It provides minimally invasive detection of tumor specific DNA. This review summarizes data on presence of circulating tumor DNA in serum or plasma of CRC patients as a potential negative prognostic factor. Materials and Methods: The systematic review was performed according to PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses). The search was performed using PubMed, Web of Science and Scopus. Results: In total 18 articles with a total of 1779 patients ma the inclusion criteria. Six out of 8 studies found that presence of ctDNA in plasma/serum was associated with inferior overall survival. All 6 studies found that high concentrations of ctDNA in plasma/serum was associated with inferior overall survival. Conclusions: Presence or high concentrations of KRAS mutation in plasma or serum were associated with inferior prognosis. Establishing cut-off concentrations is warranted for further clinical implementation of liquid biopsy.

引用

页数：9

共 63 条

[51] Disentangling the prognostic heterogeneity of stage III colorectal cancer through histologic stromal categorization [J].

Ueno, Hideki ;

Sekine, Shigeki ;

Oshiro, Taihei ;

Kanemitsu, Yukihide ;

Hamaguchi, Tetsuya ;

Shida, Dai ;

Takashima, Atsuo ;

Ishiguro, Megumi ;

Ito, Eisaku ;

Hashiguchi, Yojiro ;

Kondo, Fukuo ;

Shimazaki, Hideyuki ;

Mochizuki, Satsuki ;

Kajiwara, Yoshiki ;

Shinto, Eiji ;

Yamamoto, Junji ;

Shimada, Yasuhiro .

SURGERY, 2018, 163 (04) :777-783

[52] Histologic Categorization of Desmoplastic Reaction: Its Relevance to the Colorectal Cancer Microenvironment and Prognosis [J].

Ueno, Hideki ;

Shinto, Eiji ;

Shimazaki, Hideyuki ;

Kajiwara, Yoshiki ;

Sueyama, Takahiro ;

Yamamoto, Junji ;

Hase, Kazuo .

ANNALS OF SURGICAL ONCOLOGY, 2015, 22 (05) :1504-1512

[53] Circulating Plasma Levels of miR-20b, miR-29b and miR-155 as Predictors of Bevacizumab Efficacy in Patients with Metastatic Colorectal Cancer [J].

Ulivi, Paola ;

Canale, Matteo ;

Passardi, Alessandro ;

Marisi, Giorgia ;

Valgiusti, Martina ;

Frassineti, Giovanni Luca ;

Calistri, Daniele ;

Amadori, Dino ;

Scarpi, Emanuela .

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2018, 19 (01)

[54] Frequency of KRAS, BRAF, and NRAS Mutations in Colorectal Cancer [J].

Vaughn, Cecily P. ;

ZoBell, Scott D. ;

Furtado, Larissa V. ;

Baker, Christine L. ;

Samowitz, Wade S. .

GENES CHROMOSOMES & CANCER, 2011, 50 (05) :307-312

[55] Plasma ctDNA RAS mutation analysis for the diagnosis and treatment monitoring of metastatic colorectal cancer patients [J].

Vidal, J. ;

Muinelo, L. ;

Dalmases, A. ;

Jones, F. ;

Edelstein, D. ;

Iglesias, M. ;

Orrillo, M. ;

Abalo, A. ;

Rodriguez, C. ;

Brozos, E. ;

Vidal, Y. ;

Candamio, S. ;

Vazquez, F. ;

Ruiz, J. ;

Guix, M. ;

Visa, L. ;

Sikri, V. ;

Albanell, J. ;

Bellosillo, B. ;

Lopez, R. ;

Montagut, C. .

ANNALS OF ONCOLOGY, 2017, 28 (06) :1325-1332

[56]

Vitale P, 2019, ANN ONCOL, V30, P91

[57] Radiofrequency ablation versus resection for technically resectable colorectal liver metastasis: a propensity score analysis [J].

Wang, Li-Jun ;

Zhang, Zhong-Yi ;

Yan, Xiao-Luan ;

Yang, Wei ;

Yan, Kun ;

Xing, Bao-Cai .

WORLD JOURNAL OF SURGICAL ONCOLOGY, 2018, 16

[58] Tumour pharmacodynamics and circulating cell free DNA in patients with refractory colorectal carcinoma treated with regorafenib [J].

Wong, Andrea Li Ann ;

Lim, Joline Si Jing ;

Sinha, Arvind ;

Gopinathan, Anil ;

Lim, Robert ;

Tan, Chee-Seng ;

Soh, Thomas ;

Venkatesh, Sudhakar ;

Titin, Christina ;

Sapari, Nur Sabrina ;

Lee, Soo-Chin ;

Yong, Wei-Peng ;

Tan, David Shao Ping ;

Pang, Brendan ;

Wang, Ting-Ting ;

Zee, Ying-Kiat ;

Soong, Richie ;

Trnkova, Zuzana ;

Lathia, Chetan ;

Thiery, Jean-Paul ;

Wilhelm, Scott ;

Jeffers, Michael ;

Goh, Boon-Cher .

JOURNAL OF TRANSLATIONAL MEDICINE, 2015, 13

[59] The diagnostic accuracy of circulating free DNA for the detection of KRAS mutation status in colorectal cancer: A meta-analysis [J].

Xie, Wenli ;

Xie, Li ;

Song, Xianrang .

CANCER MEDICINE, 2019, 8 (03) :1218-1231

[60] Liquid Biopsy for the Management of Patients with Colorectal Cancer [J].

Yamada, Takeshi ;

Matsuda, Akihisa ;

Koizumi, Michihiro ;

Shinji, Seiichi ;

Takahashi, Goro ;

Iwai, Takuma ;

Takeda, Kohki ;

Ueda, Kohji ;

Yokoyama, Yasuyuki ;

Hara, Keisuke ;

Hotta, Masahiro ;

Matsumoto, Satoshi ;

Yoshida, Hiroshi .

DIGESTION, 2019, 99 (01) :39-45

← 1 2 3 4 5 6 7 →